RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Stock

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Equity 2024

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Equity

103.96 M TRY

Ticker

ONCSM.E.IS

ISIN

TREONCO00026

In 2024, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's equity was 103.96 M TRY, a 31.93% increase from the 78.8 M TRY equity in the previous year.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Aktienanalyse

What does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS do?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's Equity

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS stock

What is the equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS this year?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS has equity of 103.96 M TRY this year.

What was the equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS compared to the previous year?

The equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS has increased/decreased by 31.93% increased compared to the previous year.

What impact does a high equity have on investors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

A high equity is advantageous for investors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

A low equity can be a risk for investors of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS affect the company?

An increase in equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS affect the company?

A reduction in equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

Some factors that can affect the equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS so important for investors?

The equity of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS take to change the equity?

To change equity, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay?

Over the past 12 months, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is expected to pay a dividend of 0 TRY.

What is the dividend yield of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

The current dividend yield of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is .

When does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay dividends?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS paid dividends every year for the past 0 years.

What is the dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

For the upcoming 12 months, dividends amounting to 0 TRY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS located?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS from 11/10/2023 amounting to 0.415 TRY, you needed to have the stock in your portfolio before the ex-date on 11/8/2023.

When did Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay the last dividend?

The last dividend was paid out on 11/10/2023.

What was the dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS in the year 2023?

In the year 2023, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS distributed 0 TRY as dividends.

In which currency does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay out the dividend?

The dividends of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS are distributed in TRY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS

Our stock analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.